Balanced Growth Across All Business Divisions,
Driven by High Value-Added Logistics such as 3PL and 4PL

GeoYoung Group, whose core business is pharmaceutical distribution, surpassed 5 trillion won in annual sales for the first time since its founding.

GeoYoung Surpasses 5 Trillion Won in Annual Sales for the First Time... Growth Across Logistics, Distribution, and Diagnostics View original image

On April 1, GeoYoung announced that it recorded consolidated sales of 5.3509 trillion won and operating profit of 103.6 billion won last year. Sales rose 14.6% year-on-year, surpassing 5 trillion won for the first time, and operating profit also increased by 27.7%.


On a separate basis, sales reached 3.4849 trillion won and operating profit stood at 72.3 billion won, marking growth of 8.7% and 16.3%, respectively.


This performance is the result of balanced growth across all business divisions, including logistics, distribution, and diagnostics. In particular, high value-added logistics businesses such as third-party logistics (3PL) and fourth-party logistics (4PL) drove growth. The company’s strategy to expand its client base in response to increased demand for prescription drugs has led to tangible results.


In the pharmaceutical distribution sector, GeoYoung maintained stable growth based on a network that supplies about 80% of pharmacies nationwide and a supply chain to hospitals and clinics. Sales expanded across both online and offline channels.


Improved logistics efficiency also contributed to increased profitability. Operational efficiency improved as the Smart Hub Center entered a stable operation phase.


Subsidiary performance also provided support. Carecamp, a group purchasing organization (GPO) serving hospitals, continued to grow by expanding its supply of medical devices and clinical materials. DuechemBio, a radiopharmaceutical company, improved its results thanks to increased demand for diagnostic products for Alzheimer’s disease. The growth in demand for PET scans, driven by the introduction of global dementia treatments, was identified as a key factor.


Healthcare IT affiliates Cresoty and Forcigate also contributed to group growth by expanding their service areas.



Cho Sunhye, Chairwoman of GeoYoung, stated, “Achieving 5 trillion won in sales is a milestone that demonstrates GeoYoung’s evolution into a comprehensive healthcare platform, beyond pharmaceutical distribution,” adding, “We will continue to fulfill our role as a total healthcare partner dedicated to protecting the health and lives of the people.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing